Cellectar Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

The following table summarizes amounts charged to expense for stock-based compensation related to employee and director stock option grants and recorded in connection with stock options granted to non-employee consultants:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2015		2014		2015		2014
Employee and director stock option grants:
Research and development	$	25,749	$	31,441	$	109,402	$	142,142
General and administrative		142,319		130,700		316,755		491,665
Restructuring		—		—		—		47,853
		168,068		162,141		426,157		681,660

Non-employee consultant stock option grants:
Research and development		(3,052)		(15,582)		2,404		1,115

Total stock-based compensation	$	165,016	$	146,559	$	428,561	$	682,775

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following table summarizes weighted-average values and assumptions used for options granted to employees, directors and consultants in the periods indicated:

	Nine Months Ended			Nine Months Ended
	September 30, 2015			September 30, 2014
Volatility		105-107	%		108	%
Risk-free interest rate		1.70-1.95	%		1.76	%
Expected life (years)		6.0			6.0
Dividend		0	%		0	%
Weighted-average exercise price	$	2.65		$	7.40
Weighted-average grant-date fair value	$	2.17		$	6.20

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of stock option activity is as follows:

					Weighted
	Number of				Average
	Shares Issuable				Remaining
	Upon Exercise		Weighted		Contracted		Aggregate
	of Outstanding		Average		Term in		Intrinsic
	Options		Exercise Price		Years		Value
Outstanding at December 31, 2014		719,466	$	15.59
Granted		510,200	$	2.65
Exercised		8,333	$	2.74
Canceled		149,177	$	22.68
Forfeited		283,773	$	8.22
Outstanding at September 30, 2015		788,383	$	8.67

Vested, September 30, 2015		253,556	$	18.04		5.61	$	—
Unvested, September 30, 2015		534,827	$	3.04		9.56	$	—
Exercisable at September 30, 2015		253,556	$	18.04		5.61	$	—